Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
ESC: One Month of COVID-19 Lockdown Cost Heart Attack Patients Up to Two Years of Life
06/08/2023
Sophia Antipolis:  Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts. That’s the finding of a study published...
Sophia Antipolis:  Patients who had heart attacks during the first COVID-19 lockdown in the UK and Spain are predicted to live 1.5 and 2 years less, respectively, than their pre-COVID counterparts. That’s the finding of a study published...
Sophia Antipolis:  Patients...
06/08/2023
Cath Lab Digest

Advertisement

News
New Genetic Research Sheds Light on Association of Pre-Eclampsia With Cardiovascular Diseases
06/08/2023
A new wide-ranging Finnish study on the hereditary risk factors of pre-eclampsia showed that the pregnancy disorder and hypertension share many of the same genetic risk factors. This means that women suffering from pre-eclampsia should pay...
A new wide-ranging Finnish study on the hereditary risk factors of pre-eclampsia showed that the pregnancy disorder and hypertension share many of the same genetic risk factors. This means that women suffering from pre-eclampsia should pay...
A new wide-ranging Finnish study...
06/08/2023
Cath Lab Digest
News
Study: Heart Attack Outcomes Far Worse for Those With COVID-19
06/08/2023
New research from the Smidt Heart Institute at Cedars-Sinai shows that patients who went to a hospital with a heart attack and were simultaneously sick with COVID-19 were three times more likely to die than patients experiencing a heart...
New research from the Smidt Heart Institute at Cedars-Sinai shows that patients who went to a hospital with a heart attack and were simultaneously sick with COVID-19 were three times more likely to die than patients experiencing a heart...
New research from the Smidt...
06/08/2023
Cath Lab Digest
News
Digital Innovation Initiative Aims to Reduce Amputations
06/07/2023
June 07, 2023, RALEIGH, NC – In the United States alone, a leg is amputated every two minutes. As announced at last week's New Cardiovascular Horizons (NCVH) Annual Conference, this confronting statistic is being met head on by a digital...
June 07, 2023, RALEIGH, NC – In the United States alone, a leg is amputated every two minutes. As announced at last week's New Cardiovascular Horizons (NCVH) Annual Conference, this confronting statistic is being met head on by a digital...
June 07, 2023, RALEIGH, NC...
06/07/2023
Vascular Disease Management

Advertisement

News
First Patients Treated in the U.S. with the World’s Smallest Heart Pump
06/07/2023
Magenta Medical announced today the initiation of its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication.
Magenta Medical announced today the initiation of its FDA-approved Early Feasibility Study with the Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) for the high-risk percutaneous coronary intervention (HR-PCI) indication.
Magenta Medical announced today...
06/07/2023
Cath Lab Digest
Biotronik Oscar
News
BIOTRONIK Launches Oscar Multifunctional Peripheral Catheter at LINC 2023
06/05/2023
BUELACH, Switzerland - June 05, 2023. BIOTRONIK is pleased to announce the limited release of its Oscar® (One Solution: Cross. Adjust. Restore) multifunctional peripheral catheter and start of promotional activities at LINC, the Leipzig...
BUELACH, Switzerland - June 05, 2023. BIOTRONIK is pleased to announce the limited release of its Oscar® (One Solution: Cross. Adjust. Restore) multifunctional peripheral catheter and start of promotional activities at LINC, the Leipzig...
BUELACH, Switzerland - June 05,...
06/05/2023
Vascular Disease Management
News
Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure
06/05/2023
BASKING RIDGE, N.J. & SHIRLEY, N.Y.-- Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose...
BASKING RIDGE, N.J. & SHIRLEY, N.Y.-- Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose...
BASKING RIDGE, N.J. &...
06/05/2023
Cath Lab Digest

Advertisement

News
Valve Medical Announces Successful First-in-Human Implantation of Ultra-Low Profile TAVR Valve in Israel
06/02/2023
The Valve Medical Xemed TAVR device is designed to improve patient outcomes and procedural success. The distinguishing feature of the valve is its modular design.
The Valve Medical Xemed TAVR device is designed to improve patient outcomes and procedural success. The distinguishing feature of the valve is its modular design.
The Valve Medical Xemed TAVR...
06/02/2023
Cath Lab Digest
News
Penumbra Expands Computer-Aided Thrombectomy Offerings With Lightning Bolt 7 Technology Designed to Rapidly Remove Blood Clots with Modulated Aspiration
06/01/2023
Lightning Bolt 7 received FDA clearance and became available in March 2023. It is part of Penumbra’s Indigo® System with Lightning portfolio, which are the only computer-aided mechanical thrombectomy systems currently available in the U.S.
Lightning Bolt 7 received FDA clearance and became available in March 2023. It is part of Penumbra’s Indigo® System with Lightning portfolio, which are the only computer-aided mechanical thrombectomy systems currently available in the U.S.
Lightning Bolt 7 received FDA...
06/01/2023
Cath Lab Digest
News
AHA: 1 in 3 Adults With Type 2 Diabetes May Have Undetected Cardiovascular Disease
06/01/2023
Research Highlights: One-third of adults in the U.S. with Type 2 diabetes may have symptomless or undetected cardiovascular disease. Adults with Type 2 diabetes who do not have any signs or symptoms of cardiovascular disease are more...
Research Highlights: One-third of adults in the U.S. with Type 2 diabetes may have symptomless or undetected cardiovascular disease. Adults with Type 2 diabetes who do not have any signs or symptoms of cardiovascular disease are more...
Research...
06/01/2023
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use